epibatidine has been researched along with Parkinsonian Disorders in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fan, H; Lai, A; McIntosh, JM; Quik, M; Sum, J | 1 |
| Ahtee, L; Janhunen, S; Tuominen, RK | 1 |
| Fan, H; Kulak, JM; Schneider, JS | 1 |
3 other study(ies) available for epibatidine and Parkinsonian Disorders
| Article | Year |
|---|---|
Selective recovery of striatal 125I-alpha-conotoxinmii nicotinic receptors after nigrostriatal damage in monkeys.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Azetidines; Bridged Bicyclo Compounds, Heterocyclic; Conotoxins; Corpus Striatum; Disease Models, Animal; Dopamine Plasma Membrane Transport Proteins; Female; Iodine Radioisotopes; Male; Membrane Glycoproteins; Membrane Transport Proteins; Mice; Mice, Inbred C57BL; Nerve Tissue Proteins; Neural Pathways; Parkinsonian Disorders; Presynaptic Terminals; Pyridines; Receptors, Nicotinic; Recovery of Function; Saimiri; Substantia Nigra; Up-Regulation | 2004 |
Comparison of the effects of nicotine and epibatidine given in combination with nomifensine on rotational behaviour in rats.
Topics: Adrenergic Agents; Animals; Brain; Bridged Bicyclo Compounds, Heterocyclic; Dopamine Uptake Inhibitors; Drug Therapy, Combination; Male; Motor Activity; Nicotine; Nicotinic Agonists; Nomifensine; Oxidopamine; Parkinsonian Disorders; Pyridines; Rats; Rats, Wistar | 2005 |
Beta2* and beta4* nicotinic acetylcholine receptor expression changes with progressive parkinsonism in non-human primates.
Topics: Animals; Autoradiography; Azetidines; Brain; Bridged Bicyclo Compounds, Heterocyclic; Iodine Radioisotopes; Macaca; Nicotinic Agonists; Parkinsonian Disorders; Pyridines; Receptors, Nicotinic | 2007 |